CysBio ApS: Financial statements 2022
CVR: 40270752
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
CysBio ApS (CVR 40270752) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 5,417,524 and a net result of DKK -4,481,311 compared with DKK -13,678,022 the year before. Equity in the 2022 report amounted to DKK 17,534,608. The solvency ratio was 62.8%. The company had 15 employees in the financial year.
- Gross Profit
- DKK 5,417,524
- Profit/Loss
- DKK -4,481,311
- Equity
- DKK 17,534,608
- Total Assets
- DKK 27,940,406
- Employees
- 15
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 5.4 mio. | -4.5 mio. | 17.5 mio. | 15 |
| 2021 | - | -6.3 mio. | -13.7 mio. | 22 mio. | 4 |
| 2020 | - | 8 mio. | -21 t. | 35.7 mio. | 4 |
| 2019 | - | -2.1 mio. | -5.2 mio. | 17.2 mio. | - |
Official annual report
Keep an eye on CysBio ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
CysBio ApS has published its annual report for 2021. Gross profit came to DKK -6,310,970, and the net result was DKK -13,678,022.
About CysBio ApS
CysBio ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Alex Toftgaard Nielsen. The board consists of Alex Toftgaard Nielsen (chair), Christian Bille Jendresen and Xu Chaofeng. The company's owners include Danmarks Tekniske Universitet, Hemanshu Share Holding ApS and Christian Bille Jendresen Holding ApS. According to the 2025 annual report, the company had an average of 13 employees. In 2025, the company reported a gross profit of DKK 9,930,247 and a net result of DKK 124,708 compared with DKK -12,602,635 the year before. Equity in the 2025 report amounted to DKK -8,792,805.